MedPath

Treatment of anemia in diabetic type II patient

Phase 2
Conditions
Iron deficiency anemia.
Iron deficiency anemia
Registration Number
IRCT20190202042591N1
Lead Sponsor
Ahvaz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
100
Inclusion Criteria

Hemoglobin level 9 to 12 and 9 to 13, in order women and men
Needless to transfusion or iron infusion
The patient has just iron deficiency anemia
A1C hemoglobin level is less than 9.

Exclusion Criteria

Patients who do not sign the ethical consent form.
Patients who do not cooperate during the treatment for any reason.
Patients who are moved from oral diabetes treatment to injection for any reason during anemia treatment
Severe liver failure
History of gastric surgery
Diabetic patients who have different type of anemia

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Analysing the difference of Iron sulphate each day and every 2 days between those patients who are suffering from diabetes and are have low blood iron. Timepoint: 8weeks for group A 16weeksfor group B. Method of measurement: hemoglobin quantity.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath